Andrew Chien filed a motion in the US Bankruptcy Court seeking the conversion of Commonwealth Biotechnologies Inc.'s bankruptcy case from Chapter 11 reorganization to Chapter 7 liquidation on January 29, 2013. There are no operations and it is a shell company with no business operations. There are no substantial changes as per amendments for case conversion filed on February 4, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 USD | +6.25% |
|
0.00% | -7.61% |
1st Jan change | Capi. | |
---|---|---|
-7.61% | 14.65M | |
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-15.13% | 16.92B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B |
- Stock Market
- Equities
- INTI Stock
- News Inhibitor Therapeutics, Inc.
- Motion for Case Conversion Filed by Andrew Chien for Commonwealth Biotechnologies Inc.